Annual European Congress of Rheumatology

Abstract

The proceedings contain 3796 papers. The topics discussed include: Mdm2-mediated sumoylation of p53 contributes to the migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis; gut-derived TNF as risk factor for the development of sacroiliac inflammation; the JAK1 selective inhibitor filgotinib regulates both enthesis and colon inflammation in a mouse model of psoriatic arthritis; the initiation, but not the persistence, of experimental spondyloarthritis in HLAB27/HUβ2M transgenic rats is crucially dependent on the IL-23 axis; altered lymph node stromal cells during the earliest phases of rheumatoid arthritis; apoptosis resistance of synovial fibroblasts of patients with rheumatoid arthritis is regulated by the long non-coding RNA FAS-AS1; methotrexate increases expression of the cell cycle regulators LBH and P21 and reduces fibroblast-like synoviocyte proliferation after mitogen stimulation; prevalence of immunization of patients with autoimmune disease in Mexico; measurement of spinal mobility in axial spondyloarthritis using inertial sensors: reliability and validation preliminary results; how strong are the associations of spondyloarthritis-related comorbidities with ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis? a register-based study from Sweden; histological features of joint and colonic inflammation in inflammatory bowel disease patients treated with anti-TNF; and Erap1 is a susceptibility factor for early axial spondyloarthritis meeting the ASAS classification criteria: results from the desire and space cohorts.